149 related articles for article (PubMed ID: 10155675)
1. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
Bloom BS; Hillman AL; LaMont B; Liss C; Schwartz JS; Stever GJ
Pharmacoeconomics; 1995 Oct; 8(4):343-9. PubMed ID: 10155675
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
Bergmann JF; Hamelin B; Barbier JP
Gastroenterol Clin Biol; 1995 May; 19(5):482-6. PubMed ID: 7589999
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
[TBL] [Abstract][Full Text] [Related]
5. Cost and quality effects of treating erosive oesophagitis. A re-evaluation.
Bloom BS
Pharmacoeconomics; 1995 Aug; 8(2):139-46. PubMed ID: 10155608
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
7. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
[TBL] [Abstract][Full Text] [Related]
8. Prevention of erosive oesophagitis relapse with pantoprazole.
Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
Wahlqvist P; Junghard O; Higgins A; Green J
Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
11. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture.
Stal JM; Gregor JC; Preiksaitis HG; Reynolds RP
Can J Gastroenterol; 1998; 12(1):43-9. PubMed ID: 9544411
[TBL] [Abstract][Full Text] [Related]
12. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
Havelund T; Laursen LS; Lauritsen K
Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
[TBL] [Abstract][Full Text] [Related]
16. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L
Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
Langtry HD; Wilde MI
Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
[TBL] [Abstract][Full Text] [Related]
20. Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
Zeitoun P
Scand J Gastroenterol Suppl; 1989; 166():83-7; discussion 94. PubMed ID: 2690335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
